We develop biologic solutions to human, agricultural, and environmental disease.
Auxergen has raised $550K in total funding. The most recent round was Seed. The last funding was announced in April 2023.
Auxergen is headquartered in Baltimore, United States.
We develop biologic solutions to human, agricultural, and environmental disease.
Auxergen is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Auxergen — Funding & Investors." VCBacked, April 15, 2023, https://www.vcbacked.co/company/auxergen. Accessed July 19, 2026.
VCBacked. (2023). Auxergen — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/auxergen
{{cite web |title=Auxergen — Funding & Investors |url=https://www.vcbacked.co/company/auxergen |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated